Scinai Immunotherapeutics : The Board has Approved a Ratio C

Scinai Immunotherapeutics : The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares (equivalent to a reverse split) Designed to Regain Compliance - Form 6-K

Scinai Immunotherapeutics : The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares (equivalent to a reverse split) Designed to Regain Compliance - Form 6-K

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Jerusalem , Israel General , Israel , Scinai Immunotherapeutics , Scinai Bioservices , Company Contacts , Company American Depositary Shares Adss , Scinai Immunotherapeutics Ltd , Nasdaq Hearings Panel The , Nasdaq , Listing Qualifications Department The Staff , Nasdaq Stock Market , Business Development , Ratio Change , Non Traded Ordinary Shares , Regain Compliance , Listing Qualifications Department , Nasdaq Listing Rule , American Depositary Shares , Nasdaq Capital Market , Nasdaq Hearings Panel ,